In terms of steroid strength, it is more potent than hydrocortisone, and less potent than dexamethasone.Some low-quality evidence suggests the use of mometasone for symptomatic improvement in children with adenoid hypertrophy.Mometasone is used to alleviate inflammation and itchiness in skin conditions that respond to treatment with glucocorticoids such as psoriasis and atopic dermatitis.Nasal mometasone is used in adults (including the elderly) and children over two years of age, to diminish the symptoms of hay fever (seasonal allergic rhinitis) and other allergies (perennial rhinitis), including nasal congestion, discharge, pruritus, and sneezing and to treat nasal polyps.It is not useful for the common cold. Asthma
Mometasone furoate can be used with formoterol for the treatment of asthma, due to its anti-inflammatory properties. Contraindications
People should not use inhaled mometasone or mometasone nasal spray if:

glaucoma or cataracts
hypersensitivity or allergic to any ingredient in mometasoneThose who are using mometasone nasal or inhaled for a long period of time (e.g. more than three months) should get regular eye exams to check for glaucoma and cataracts and should take precautions to avoid infections such as taking a vitamin D supplement, staying away from those with an infection (chickenpox, measles, colds or flu, COVID-19), washing foods, hand washing and calling a family doctor at the first sign of a severe infection. People should not use mometasone topical (skin cream) if:

hypersensitive or allergic to any ingredient in the skin creamMometasone furoate is in class C in terms of safety while use during pregnancy. Therefore, its risks to the baby cannot be ruled out.
Primarily nuclear imaging techniques such as single-photon emission computed tomography (SPECT), positron emission tomography (PET), and bone scintigraphy are taken along with other data before a patient is diagnosed for Condylar Hyperplasia. In SPECT imaging, an increase uptake of the isotope is seen on the affected in comparison to the non-affected side. A difference of at least 10% or a minimum ratio of 55% to 45% uptake of technetium-99m is seen when comparing affected vs non-affected side respectively. An uptake of more than 55% and difference of at least 10% indicates an active condylar growth. Classification
Hugo Obwegesr and Makek classified condylar hyperplasia into three categories, listed in the table below. Type 1 develops its characteristics from the horizontal vector, and Type 2 develops its characteristics from the vertical vector. Type 1 CH occurs much more common (15x) than Type 2 CH. Wolford et al. in 2014, developed an updated classification of condylar hyperplasia. In 1986, Slootweg & Muller devised a histopathological classification which allows the condylar tissues to be classified into specific categories. Treatment
Many treatment options exist for this type of condition. Orthognathic surgery can be performed once the active condylar growth has finished in some cases. The point of this surgery to wait as long as the condyle is growing and only do surgery when the condyle stops growing, so the chances of any worsening of facial asymmetry lessens. This option, however, does include a person living with the facial asymmetry features all the way up until 18 to 19 years of age.